Get started

DRYS

Will Get Pumped Soon. Near The Bottom Of It's Range. No VolumeOne of those Greek drybulk shipping stocks. A new one on the block. Thalassa Investment Co. S.A.(of the Democratic Republic of Liberia) owns 1,124,094 common shares Universe Shipping Inc.(Republic of Marshall Islands) owns 235,200 common shares Common shares outstanding is currently 2,400,000 " We are incorporated in the Republic of the Marshall Islands, which does not have a well-developed body of corporate law, and as a result, shareholders may have fewer rights and protections under Marshall Islands law than under a typical jurisdiction in the United States". Shareholders' Equity: $9,474,582 6/28/19 We have entered into an equity distribution agreement with Maxim Group LLC pursuant to which we may issue and sell up to an aggregate of $10,000,000 of our common shares. Maxim Group LLC may sell our common shares by any method permitted by law deemed to be an "at-the-market" offering (F-3 approved by the SEC on June.21st for 100 million). Commission equal to 3% of the aggregate gross proceeds Doesn't get more obvious than this.... Our Chairman, Chief Executive Officer and Chief Financial Officer, Mr. Petros Panagiotidis, may be deemed to beneficially own, directly or indirectly, all of the 12,000 outstanding shares of our Series B Preferred Stock. The shares of Series B Preferred Stock each carry 100,000 votes. 1.2 billion votes.............Better believe the SEC will be watching this closely. There is a huge risk of a trading halt. This guy is sloppy, and clearly doesn't care about subtleties. If it starts to go supernova, like 200% or more, immediately sell. Even 150%. Don't push your luck
NASDAQ:CTRMLong
by InteractiveSwingTrading
4
9 Million Warrants Priced At 1.62. Short, Medium size, Entry 3/4The Stated Value of the Preferred Shares is $20.00 per unit, and the annual interest payment, which is to be paid out in quarterly installments, is 8%". That translates into $2,000,000 worth of shares per year. In regards to the warrants, if we multiply 7.41 by 1 250 000, we get 9,262,500 common shares, and it says that the warrants are exercisible ***immediately @ $1.62 per share*** During the 60 days prior to May 31, 2019, and from the Event Date to the date hereof, Arosa Capital, on behalf of Arosa Opportunistic Fund, sold 178,333 shares of Common Stock, as follows: Date Quantity Price Type of Transaction May 2, 2019 159,955 $0.9074 Open Market Sale May 3, 2019 18,378 $0.9165 Open Market Sale Says a lot about how much confidence they had in the valuation at that time, and this was before Trump pumped it on twitter. On May 31, 2019, the Company entered into a Subscription Agreement with Arosa Opportunistic Fund, in which Arosa Opportunistic Fund purchased (i) 305,000 shares of Series B Preferred Stock, with a stated value of $20.00 per share (the “Stated Value”) and a par value of $0.001 per share (the “Preferred Stock”), and (ii) warrants to purchase up to 2,260,050 shares of Common Stock at an exercise price of $1.62 per share (the “2019 Warrants” and together with the 2018 Warrants, the “Warrants”), subject to the Exercise Limitation. The Preferred Stock is not convertible and does not hold voting rights. The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% simple interest per annum on the Stated Value. Accrued dividends are payable quarterly in shares of Common Stock based on a share price of $1.62. 1 250 000/305 000= 4.09(2,260,050) = The amount of warrants the preferred share holders are entitled to receive as part of the preferred share units There is also warrants exercisible at $1.25 We should assume that the rest of the warrants went to Marathon This chart pattern, and the way to price closed today, is almost a sure fire indication that they are unloading some of those warrants. Cheers, and happy trading everyone. **********WE ARE NOT FINANCIAL ADVISERS. THIS IS A HIGH RISK TRADE. CONSULT A FINANCIAL ADVISER BEFORE BUYING ANY PUBLICLY TRADED SECURITY. WE DO NOT OWN THIS STOCK, NOR DO WE INTEND TO BUY THIS STOCK IN THE NEAR FUTURE. WE ARE NOT BEING PAID TO WRITE THIS OR BEING COMPENSATED IN ANYWAY. YOU SHOULD NOT USE THIS INFORMATION AS INVESTMENT ADVISE. ALSO, BY READING THIS ARTICLE, YOU AGREE TO INDEMNIFY US OF ALL LIABILITY FOR ANY LOSSES INCURRED FROM USING OUR INFORMATION AS THE BASIS OF AN INVESTMENT DECISION *****
NASDAQ:WKHSShort
by InteractiveSwingTrading
1
$CTRM Bases at Support for Next Leg Up PPS Target Still $8.00+Algoritmic Entities Brought Castor down to the $6.00 support earlier today and bounced it off it nicely after which NSDQ known for driving the stock up or down accumulated shares at that level and begun slowly pushing the stock up on bid. I do believe she is ready for the next leg up and have accumulated all I could. Remember the stock started trading on the NASDAQ in Feb of this year and has already had 4 major spikes. I anticipate another one should be coming within the week given the Baltic Dry Index has been on a tear since Feb. I also anticipate more updates from the company since it is newly trading and just launched their major ship in March. Happy Trading!!!
NASDAQ:CTRMLong
by StockGuild
VDRM FULL DD PACKAGEALL THE DD ON VDRM YOU NEED RIGHT HERE (repost) 2dollarbill Saturday, 08/19/17 10:19:12 AM Re: None Post # 26410 of 26411 Go ALL THE DD ON VDRM YOU NEED RIGHT HERE FDA approved products that ViaDerma (VDRM) offers: -skin cancer therapies (Cantrile) -stem cell therapy product (TetraStem Plus) -topical antibiotics (TetraStem the world’s strongest broad-spectrum topical antibiotic available) -TETRA-STEM – a tetracycline hydrochloride ointment. An award-winning antibiotic/wound healing product that kills all knows bacteria, including "flesh-eating" bacteria. Tertra-stem also can be used to treat wounds, ulcers -topical anti-viral product (Viralcur) for genital herpes anti-fungal products for onychomycocis (OnyPro) -hair loss prevention product (HairGain) -ACNECLIR/ACNEEN – a salicylic acid based lotion that treats acne -ECODERM – a colloidal oatmeal lotion for Eczema -ACNECYCLINE – a tetracycline hydrochloride ointment that treats acne -DERMONEEN – a salicylic acid lotion used to treat Psoriasis -IVYMED – a zinc acetate based liquid that treats Poison Ivy rashes - STAPHWASH PLUS – a zinc acetate based liquid. This is a non-antibiotic skin cleanser that kills MRSA -TETRA-ABC – a tetracycline hydrochloride based ointment. This is an oil based topical antibiotic that kills all known bacterial infections. A water based version of this product is also available. -STINGMED – a zinc acetate based liquid that treats most insect and spider bites -ADVANCED JELLYFISH STING KIT – a zinc acetate powder, for suspension, that treats Jellyfish stings -VENOMX – a zinc acetate based liquid used topically to treat snake bites. -Product for treatment of Migraines presently; with a future of possibly ( inflammation of fibromyalgia, Cohn’s disease, nicotine addiction, schizophrenia, and pain management for Multiple Sclerosis and cancer. utilizing (CBD's) Calanoids and (THC) Tetrahydrocannabinol biotechs trade at 30x earnings or 5x gross sales or 15x net sales or on air if they are a r and d company, with VDRM we have sales coming this year here is the analysis broken down below ie...from the 500,000 bottles alone will yield $62.5M gross sales $62.5m in gross sales X 5x gross sales = 325m market cap = $1.00 - $1.50 target OR 62.5m in gross sales @ a 50% margin = $31m in net sales X 15x net sales = 450m market cap = $2.00 + target OR 62.5m in gross sales with a $31m in net sales which divided by outstanding stock = 0.15 cents earnings X 30x earnings (pe - price to earnings) = $4.50 + target Lead Product TetraStem World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile. Potential Markets ViaDerma is developing products in many fields of use, including: Topical antibiotics- $6 billion/year Toenail antifungal drugs- $3 billion/year Diabetic amputations- $3 billion/year Global acne- $3.02 billion/year Psoriasis- $7.3 billion/year Eczema- $2.5 billion/year Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transformoral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action. Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with
OTC:VDRMLong
by Cryptocol
$GRDO Continues its Uptrend on Higher Accumulation + UpdatesClick this link to read the Massive *Rolling DD Packet* We have put together for this Stock: sunnymoneyfamily.com Here is the news that got released just today: $GRDO News Shareholder letter! International Venture Society Presents the Following Shareholder Updates (OTC PINK: GRDO) International Venture Society (IVS) is pleased to announce that the custodianship proceedings for Guard Dog, Inc. (GRDO), Media G3, Inc. (MDGC) and MC Endeavors, Inc. (MSMY) were successfully adjudicated on its merits and granted in favor of IVS. The company, through its attorneys, will provide to the courts a 90 day status report on progressions made in regard to state charter revival, company reconstruction, merger candidates and regulatory compliance. In order to satisfy obligations to the courts, shareholders and potential merging/acquisition candidates, we will begin taking the necessary steps to seek reinstatement of the Nevada charters in the following weeks. “I am hopeful that the stockholders of the individual companies will view the courts' decision as a vital first step for International Venture Society to construct these long non-operational OTC companies into legitimate businesses once again,”stated International Venture Society CEO Kelani Long. “While our attorneys start working toward charter renewals, I will be evaluating possible business models as well as mergers candidates for the companies.” $GRDO tweet reply from the Company that Bill Shaefer has nothing whatsoever to do with this shell any longer! twitter.com $GRDO tweet on upcoming company updates smile twitter.com FYI in order take-over a stock-shell through_the courts in a Custodianship case as opposed to buying one you have to have a business model and a timeframe for what you are doing. You also have to bring the stock current and follow guidelines set out in the case. A public shell can cost anywhere from $35,000 to $600,000 depending on the shell you are buying. Knowing that surely the courts will make sure a legitimate company will be taking over the symbol. Courts don't just take away and hand out dormant stock shells to someone else with no purpose! This should get very interesting in the coming weeks!!!
GLong
by StockGuild
$VCPS Wine Club and App Patent Approval Could Send This .01+***$VCPS GROUNDBREAKING WINE INDUSTRY APP LAUNCH*** VCPS is an OTC Pink stock that is current and trademarked in the wine industry with a mobile app; patent pending. The wine industry is expected to continue it’s exponential growth in 2017. VinCompass seems to have a leg up on this projection with the amount of effort they have put into their brand. Special Wine club The VinCompass Signature Series Wine Club is a key component of our members' ongoing wine journeys. Featured wines are true to their places of origin, but also demonstrate innovations in winemaking that make them must-haves for those interested in expanding their wine experiences. While not all the featured wines have cellaring potential, they will all bring delight to your table. VinCompass Currently has a Wine Club that will bring in substantial income a rundown of which follows: Wines $50 and under: 3 Per Month $90 Monthly Payment 6 Per Month $180 Monthly Payment 9 Per Month $270 Monthly Payment 12 Per Month $360 Monthly Payment Wines over $50 but under $100: 3 Per Month $180 Monthly Payment 6 Per Month $360 Monthly Payment 9 Per Month $540 Monthly Payment 12 Per Month $720 Monthly Payment Wines over $100: 3 Per Month $270 Monthly Payment 6 Per Month $540 Monthly Payment 9 Per Month $810 Monthly Payment 12 Per Month $1080 Monthly Payment VinCompass is a wine company that is working on a patent pending application similar to Leafly (marijuana) and Zillow (real estate) but for the wine Industry. Their application is downloadable on both the Android and Apple App Stores. Access to their application is currently by invitation only. Per their website you can request an invitation code via staff@vincompass.com (This is thought as a testing phase before the approval of their patent.) Their application is patent pending and has been projected to be granted in 2017. The company has been noticeably busy on OTCMarkets as of June 2017 and the CEO has even purchased 18 million company shares at a higher price than it was worth at the time per Form 5. It is thought that the patent may already be granted and they are getting their filings up to date and buying company stock before announcing anything.
VLong
by StockGuild
$HAON Pays off Debt, Cancels Shares, Sells subsidiaries for $3M$HAON is in the final stages of a spin out and merger transaction that has been in the works for the past several months. Two of $HAON's wholly-owned brands which have over 300,000 consumers on their customer lists are in the ever-growing scrapbooking marketplace. These two brands are in the process of being spun out into an online social marketing/digital storage company which is currently a public company. The Company anticipates that the acquiring company's platform may be able to fill the gap as a cross between Facebook, Inc. in social marketing, and Ancestry.com in researching public records. In exchange, shareholders of Halitron, Inc. (otc pink:HAON) are currently expected to receive a stock dividend of 40 shares of the digital scrapbooking company's common stock for every 1,000 shares of Halitron, Inc. common stock owned, subject to review and approval by the Financial Industry Regulatory Authority (FINRA). The primary assets acquired were the brands, and associated customer lists, Web sites, and creative artwork. The brands have been operating on idle through the second half of the year contemplating a capital infusion to implement the Company's growth plans with regard to those brands. Halitron is on target to raise the $300,000 necessary to proportionately increase sales of its four existing legacy brands to between $3 to $5 million annually. Halitron engaged Freidman LLP to audit the books and records of Halitron in preparation for listing on the OTCQB market. On July 14th $HAON Cancelled 1.3 Billion Shares and Closed Section 3(a)(10) Debt Transaction. The Debt Transaction Canceled and Fully Diluted Shares Outstanding Decreased by 31% $HAON announced that the two final payments totaling $63,471 that were forecasted to be paid through the issuance of an estimated 1.3 Billion free trading shares based on the Section 3(a)(10) Fairness Hearing process as outlined in the Form 8-K filing with the Securities and Exchange Commission on May 15, 2017 will not be completed and the share reserve agreement has been canceled. Management decided it was in the best interests of Halitron, Inc. shareholders to negotiate the closure of the Section 3(a)(10) agreement with Northbridge Financial. One of the main objectives of going through the Section 3(a)(10) was to get professional fees paid in full so we can complete the objective of finishing the audit. Those payments were made in full. Significant payments were made against the other vendors which has only $63,471 remaining and Management feels that through upcoming transactions we will be able to honor those commitments and advance the Company's growth model. On July 18th $HAON Sold Two Brands in $3+ Million Deal Halitron, Inc. Sold Two Archival Brands to Life's Time Capsule Services, Inc. (LTCP) and Received 2.8M LTCP Restricted Common Shares plus 80M Preferred Stock C of LTCP The two brands owned by Halitron were: Archival Photo Pages and Archival Museum Supplies The Company plans to distribute the preferred shares to its shareholders of record of Halitron as of September 29, 2017. The Company believes the value of the Preferred Stock C to be approximately $3M, or about $.0375 per share ($3,000,000 / approximately 80,000,000 shares outstanding = approximately $0.0375 per share). The Preferred Stock C has the right to a fixed dividend payment due in three years on July 18, 2020, in the amount of $0.0375, which shall be paid in the form of cash, assuming profitable, or Life's Time Capsule shares of common stock at the time of payment; the payment form is at the Company's discretion. As previously reported, Management anticipates completing the audit shortly and preparing and filing a super Form 10-K with required disclosures dating back to 2008 shortly thereafter, at which time HAON will become a reporting Pink Sheet OTC Market company.
OTC:HAONLong
by StockGuild
1
$GLBS Excellent Overall Day from All time lows Uptrend Confirmed$GLBS Had an excellent technical day today. Breakout back over the cloud and major buying power into the close. With financials dropping in the next few days there could be reason for this most reason push. The night before $TOPS financials dropped there was a major push the next day after Fins were released A/H's the stock saw a cumulative 150% move in two days. $GLBS could be seeing a major technical push in addition to Moody's becoming bullish on the sector moving back up and the BDI becoming positive again all culminates in a possible ROI of 300% with $GLBS's current S/S. $GLBS has always been one of the top stocks in the shipping sector. Sentiment: Bullish
NASDAQ:GLBSLong
by StockGuild
$USRM From .0045 Onwards She is Ready for the 4th Leg UpBy far one of my top 3 favorite stocks so far this year, our Bio baby has proven her stamina. She has hit the .08 support at triple bottom and is ready for a 4th massive move upwards. With Institutional investors now throwing upwards of $5 million in financing at her for a stake in what is to be a potential FDA approval after a more than likely RMAT approval, its no wonder she is up almost 20,000% as of today from where we first found her. This is a perfect time to get back in if you already sold and are looking for another entry point for the next leg up.
OTC:USRMLong
by StockGuild
$OWCP Why I'm Extremely Long on This $5.00 by EOMI was in on the initial run .0030 - .10 bought and sold from .10 - $3.00 bought and sold (both times sold too early) and now .50 - $5.00 Here's why: PROVISIONAL PATENTS TAKE ABOUT 8-12 MONTHS TO GET TURNED INTO APPROVED PATENTS. Here's the list of $OWCP Patents: 1) patentscope.wipo.int 2) patentscope.wipo.int 3) patentscope.wipo.int 4) patentscope.wipo.int 5) patentscope.wipo.int 6) patentscope.wipo.int 7) patentscope.wipo.int Also the Patent Document: www.docdroid.net FROM THE 8K ON APRIL 4TH: OWC Pharmaceutical Research Corp. ("OWC") is reporting the issuance on April 5, 2017 of the attached press release, announcing that as a result of the promising conclusions reported in its Form 8-K filed on March 20, 2017, the Company has received expressions of scientific and medical interest, world-wide, for its cannabinoid-based topical cream for treating psoriasis. OWCP has expanded the size and scope of its clinical studies and, as previously announced, anticipates that subject to pending regulatory approvals from applicable jurisdictions, the topical cream should be available for use by those who suffer from psoriasis in the near term. ALSO LETS NOT FORGET 4/20 In addition we have many news outlets covering MJ which is bringing it back into the light. CANADA LEGALIZING IT NATIONWIDE. Too many catalysts to cover. Once we break key resistance tomorrow we could see $2.00 by EOD
OTC:OWCPLong
by StockGuild
$ATTBF Bio and Marijuana All In One 4/20 and MJ Rush PlayWell 4/20 is almost here and our favorite MJ stocks are slowly starting to create uptrends. One of my favorite ones has always been $ATTBF It saw a massive move today and seeks to attain its old fond highs of $1.00+ from the first rush back in 2014. A lot of people went disenfranchised because they thought the trend was dead due to the AG. However he is feeling a lot of resistance and Canada is to legalize MJ recreationally in the next few weeks. This being mainly located in Canada will have a massive boost from it.
OTC:ATTBFLong
by StockGuild